Imunon Stock Quote IMNN - Stock Price, News, Charts, Message Board, Trades

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

1.15

Bid

1.11

Ask

1.15

Volume

129,040

1.10 Day's Range 1.19

0.48 52 Week Range 2.00

Market Cap

10.811M

Previous Close

1.17

Open

1.19

Last Trade

1.11

Last Trade Time

19:31:53

Financial Volume

$ 147,758

VWAP

1.1451

Average Volume (3m)

34,227

Shares Outstanding

9,400,889

Dividend Yield

PE Ratio

-0.55

Earnings Per Share (EPS)

-2.08

Revenue

Net Profit

-19.52M

Imunon Inc is developing new medicines that harness the building blocks of life to work in harmony with the body's immune system. It is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the body's natural mechanisms to gen... Imunon Inc is developing new medicines that harness the building blocks of life to work in harmony with the body's immune system. It is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. Show more

Sector

Pharmaceutical Preparations

Industry

Health Care Diversified

Website

www.imunon.com

Headquarters

Dover, Delaware, USA

Founded

1982

Imunon Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker IMNN. The last closing price for Imunon was $1.17. Over the last year, Imunon shares have traded in a share price range of $ 0.48 to $ 2.00.

Imunon currently has 9,400,889 shares outstanding. The market capitalization of Imunon is $11 million. Imunon has a price to earnings ratio (PE ratio) of -0.55.

IMUNON Announces Database Lock for Phase 2 OVATION 2 Study with IMNN-001 in Advanced Ovarian Cancer

Novel IL-12 Immunotherapy Administered with Standard of Care as First-Line Treatment Expects topline results by the end of July LAWRENCEVILLE, N.J., June 24, 2024 (GLOBE NEWSWIRE) -- IMUNON...

Form 4 - Statement of changes in beneficial ownership of securities

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.27	-19.014084507	1.42	1.46	1.1	77781	1.25309528	CS
4	-0.09	-7.25806451613	1.24	1.53	1.1	44595	1.3188047	CS
12	-0.14	-10.8527131783	1.29	1.57	1.03	34227	1.32746072	CS
26	0.57	98.275862069	0.58	2	0.48	129807	1.21666896	CS
52	-0.12	-9.44881889764	1.27	2	0.48	81183	1.1471479	CS
156	-0.81	-41.3265306122	1.96	2	0.48	66453	1.24841843	CS
260	-0.81	-41.3265306122	1.96	2	0.48	66453	1.24841843	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
CGTXCognition Therapeutics Inc	$ 3.49 (47.26%)	4.67M
RNAZTransCode Therapeutics Inc	$ 0.365 (23.48%)	6.79M
NAMSNewAmsterdam Pharma Company NV	$ 22.49 (19.25%)	18.82k
YIBOPlanet Image International Ltd	$ 3.40 (16.64%)	62.92k
YYGHYY Group Holding Ltd	$ 0.84 (14.60%)	743
VTVTvTv Therapeutics Inc	$ 13.0022 (-38.67%)	33.35k
CEROCERo Therapeutics Holdings Inc	$ 0.169 (-33.98%)	3.64M
TGLTreasure Global Inc	$ 1.40 (-24.32%)	54.67k
LUXHLuxUrban Hotels Inc	$ 0.1586 (-16.96%)	1.31M
GVHGlobavend Holdings Ltd	$ 0.6302 (-13.06%)	47.77k
SLNASelina Hospitality PLC	$ 0.0265 (-11.67%)	25.19M
RNAZTransCode Therapeutics Inc	$ 0.365 (23.48%)	6.79M
CGTXCognition Therapeutics Inc	$ 3.49 (47.26%)	4.67M
TLTiShares 20 plus Year Treasury Bond	$ 92.90 (-0.10%)	3.91M
CEROCERo Therapeutics Holdings Inc	$ 0.169 (-33.98%)	3.64M